Trends and Risk Factors Associated With Stroke Recurrence in China, 2007-2018

被引:89
作者
Xu, Jie [1 ,2 ]
Zhang, Xing [1 ,2 ]
Jin, Aoming [1 ]
Pan, Yuesong [1 ]
Li, Zixiao [1 ,2 ]
Meng, Xia [1 ,2 ]
Wang, Yongjun [1 ,2 ,3 ,4 ,5 ]
机构
[1] China Natl Clin Res Ctr Neurol Dis, 119 S 4th Ring W Rd, Beijing 100070, Peoples R China
[2] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China
[3] Capital Med Univ, Adv Innovat Ctr Human Brain Protect, Beijing, Peoples R China
[4] Chinese Acad Med Sci, Res Unit Artificial Intelligence Cerebrovasc Dis, 2019RU018, Beijing, Peoples R China
[5] Chinese Acad Sci, Ctr Excellence Brain Sci & Intelligence Technol, Shanghai, Peoples R China
基金
中国国家自然科学基金;
关键词
TRANSIENT ISCHEMIC ATTACK; DENSITY-LIPOPROTEIN CHOLESTEROL; HEALTH-CARE PROFESSIONALS; SECONDARY PREVENTION; GUIDELINES; DISEASE; METAANALYSIS; OUTCOMES; ASPIRIN; TRIAL;
D O I
10.1001/jamanetworkopen.2022.16341
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IMPORTANCE Recurrent stroke rates have decreased substantially in Western countries. However, data on changes in stroke recurrence and risk factor patterns in China are limited. OBJECTIVE To systematically assess stroke recurrence trends by evaluating temporal improvement in guideline-recommended secondary prevention treatment performance and changes in risk factor patterns over 10 years in China. DESIGN, SETTING, AND PARTICIPANTS This post hoc cohort study was conducted based on data from the China National Stroke Registries (CNSRs, comprising 3 phases, from 2007-2018). Participants were patients with ischemic stroke who were enrolled in CNSR I or III within 7 days of symptom onset. Data were analyzed from September through November 2021. EXPOSURES Vascular risk factors included current smoking, alcohol consumption, hypertension, diabetes, coronary artery disease, atrial fibrillation, and low-density lipoprotein cholesterol (LDL-C) levels. MAIN OUTCOMES AND MEASURES The cumulative incidence rates of stroke recurrence at 3, 6, and 12 months were calculated, and the performance of guideline-based secondary prevention treatments was investigated at each visit in CNSR I (2007-2008) and III (2015-2018). Logistic regression models were used to evaluate changes in risk factor patterns for stroke recurrence based on data from CNSR I and III. RESULTS A total of 10 952 patients with ischemic stroke from CNSR I (6740 [61.5%] men; median [IQR] age, 67 [57-75] years) and 10 348 patients with ischemic stroke from CNSR III (7128 [68.9%] men; median [IQR] age, 63 [54-70] years) were selected. Over 10 years, the adjusted cumulative incidence of recurrent stroke within 12 months decreased from 15.5% (95% CI, 14.8%16.2%) to 12.5% (95% CI, 11.9%-13.1%) (P < .001). Factors associated with increased risk of stroke in CNSR I that were still associated after 10 years included age per 10 years (CNSR I: odds ratio [OR], 124; 95% CI, 1.18-1.31; CNSR OR, 1.08; 95% CI, 1.01-1.15), prior stroke (CNSR I: OR, 1.62; 95% CI, 1.45-1.82; CNSR III: OR, 1.66; 95% CI, 1.44-1.92), coronary heart disease (CNSR OR, 1.21; 95% CI, 1.04-1.40; CNSR III: OR, 123; 95% CI, 1.02-1.49), and LDL-C level per 10 mg/dL (0.259 mmol/L) (CNSR I: OR, 1.02; 95% CI, 1.01-1.04; CNSR III: OR, 1.02; 95% CI, 1.00-1.03), whereas atrial fibrillation (CNSR I: OR, 1.51; 95% CI, 1.26-1.81; CNSR OR, 0.95; 95% CI, 0.74-1.23) was no longer an independent risk factor in 2015 to 2018. CONCLUSIONS AND RELEVANCE This study found that stroke recurrence rate in China decreased significantly, but approximately 12.5% of patients still experienced stroke recurrence within 12 months. These findings suggest that more intensive control of traditional risk factors, including LDL-C levels, may be needed to further reduce stroke recurrence.
引用
收藏
页数:11
相关论文
共 37 条
[1]   Effects of intense low-density lipoprotein cholesterol reduction in patients with stroke or transient ischemic attack - The stroke prevention by aggressive reduction in cholesterol levels (SPARCL) trial [J].
Amarenco, Pierre ;
Goldstein, Larry B. ;
Szarek, Michael ;
Sillesen, Henrik ;
Rudolph, Amy E. ;
Callahan, Alfred, III ;
Hennerici, Michael ;
Simunovic, Lisa ;
Zivin, Justin A. ;
Welch, K. Michael A. .
STROKE, 2007, 38 (12) :3198-3204
[2]  
Amarenco P, 2006, NEW ENGL J MED, V355, P549
[3]   Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials [J].
Baigent, C. ;
Blackwell, L. ;
Emberson, J. ;
Holland, L. E. ;
Reith, C. ;
Bhala, N. ;
Peto, R. ;
Barnes, E. H. ;
Keech, A. ;
Simes, J. ;
Collins, R. .
LANCET, 2010, 376 (9753) :1670-1681
[4]   One-Year Incidence, Time Trends, and Predictors of Recurrent Ischemic Stroke in Sweden From 1998 to 2010 An Observational Study [J].
Bergstrom, Lisa ;
Irewall, Anna-Lotta ;
Soderstrom, Lars ;
Ogren, Joachim ;
Laurell, Katarina ;
Mooe, Thomas .
STROKE, 2017, 48 (08) :2046-+
[5]   Achievement of Dual Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein Targets More Frequent With the Addition of Ezetimibe to Simvastatin and Associated With Better Outcomes in IMPROVE-IT [J].
Bohula, Erin A. ;
Giugliano, Robert P. ;
Cannon, Christopher P. ;
Zhou, Jing ;
Murphy, Sabina A. ;
White, Jennifer A. ;
Tershakovec, Andrew M. ;
Blazing, Michael A. ;
Braunwald, Eugene .
CIRCULATION, 2015, 132 (13) :1224-1233
[6]   CAST: Randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke [J].
Chen, ZM ;
Hui, JM ;
Liu, LS ;
Liu, ZM ;
Peto, R ;
Sandercock, P ;
Wang, WQ ;
Wang, YX ;
Wang, ZB ;
Xie, JX ;
You, GX ;
Zhang, FL ;
Zhang, HQ ;
Zhao, ZY .
LANCET, 1997, 349 (9066) :1641-1649
[7]  
Chinese Society of Neurology, 2015, Chin J Neurol, V48, P246, DOI DOI 10.3760/CMA.J.ISSN.1006-7876.2015.04.002
[8]   Risk and Secondary Prevention of Stroke Recurrence A Population-Base Cohort Study [J].
Flach, Clare ;
Muruet, Walter ;
Wolfe, Charles D. A. ;
Bhalla, Ajay ;
Douiri, Abdel .
STROKE, 2020, 51 (08) :2435-2444
[9]   MECHANISMS OF DIABETIC COMPLICATIONS [J].
Forbes, Josephine M. ;
Cooper, Mark E. .
PHYSIOLOGICAL REVIEWS, 2013, 93 (01) :137-188
[10]   Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association [J].
Furie, Karen L. ;
Kasner, Scott E. ;
Adams, Robert J. ;
Albers, Gregory W. ;
Bush, Ruth L. ;
Fagan, Susan C. ;
Halperin, Jonathan L. ;
Johnston, S. Claiborne ;
Katzan, Irene ;
Kernan, Walter N. ;
Mitchell, Pamela H. ;
Ovbiagele, Bruce ;
Palesch, Yuko Y. ;
Sacco, Ralph L. ;
Schwamm, Lee H. ;
Wassertheil-Smoller, Sylvia ;
Turan, Tanya N. ;
Wentworth, Deidre .
STROKE, 2011, 42 (01) :227-276